• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺肿瘤中的微小RNA表达谱

MicroRNA expression profiles in thyroid tumors.

作者信息

Nikiforova Marina N, Chiosea Simon I, Nikiforov Yuri E

机构信息

Department of Pathology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15213, USA.

出版信息

Endocr Pathol. 2009 Summer;20(2):85-91. doi: 10.1007/s12022-009-9069-z.

DOI:10.1007/s12022-009-9069-z
PMID:19352602
Abstract

MicroRNAs (miRNAs) constitute a recently identified class of small endogenous noncoding RNAs that act as negative regulators of the protein-coding gene expression and may impact cell differentiation, proliferation and survival, i.e., all fundamental cellular processes implicated in carcinogenesis. miRNA expression is deregulated in many types of human cancers, including thyroid cancer. The purpose of this review is to summarize the existing findings of miRNA deregulation in thyroid tumors and its potential role in thyroid cancer biology and molecular diagnostics.

摘要

微小RNA(miRNA)是最近发现的一类内源性小非编码RNA,它们作为蛋白质编码基因表达的负调节因子,可能影响细胞分化、增殖和存活,即参与致癌作用的所有基本细胞过程。miRNA表达在包括甲状腺癌在内的多种人类癌症中失调。本综述的目的是总结甲状腺肿瘤中miRNA失调的现有发现及其在甲状腺癌生物学和分子诊断中的潜在作用。

相似文献

1
MicroRNA expression profiles in thyroid tumors.甲状腺肿瘤中的微小RNA表达谱
Endocr Pathol. 2009 Summer;20(2):85-91. doi: 10.1007/s12022-009-9069-z.
2
Deregulation of microRNA expression in thyroid tumors.甲状腺肿瘤中 microRNA 表达的失调。
J Zhejiang Univ Sci B. 2014 Mar;15(3):212-24. doi: 10.1631/jzus.B1300192.
3
The role of microRNA genes in papillary thyroid carcinoma.微小RNA基因在甲状腺乳头状癌中的作用。
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19075-80. doi: 10.1073/pnas.0509603102. Epub 2005 Dec 19.
4
Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers.微小RNA146b、221、222及p27Kip1蛋白mRNA表达水平与甲状腺乳头状癌临床病理参数的相关性
Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):137-43. doi: 10.1055/s-0034-1367025. Epub 2014 Mar 18.
5
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.14q32编码的微小RNA的下调及miR-654-3p在甲状腺乳头状癌中的肿瘤抑制作用
Oncotarget. 2017 Feb 7;8(6):9597-9607. doi: 10.18632/oncotarget.14162.
6
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.微小RNA-451a在甲状腺乳头状癌中表达下调并靶向AKT/哺乳动物雷帕霉素靶蛋白信号通路。
Oncotarget. 2016 Mar 15;7(11):12731-47. doi: 10.18632/oncotarget.7262.
7
Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.微小RNA-181b的下调通过靶向去泛素化酶CYLD促进甲状腺乳头状癌细胞凋亡。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7672-80. eCollection 2014.
8
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.ret/PTC 1重排在甲状腺乳头状癌模型中对转录及转录后调控的影响
Mol Cancer. 2006 Dec 11;5:70. doi: 10.1186/1476-4598-5-70.
9
Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.微小RNA在甲状腺乳头状癌中的临床病理影响:一项重要综述。
Exp Mol Pathol. 2015 Dec;99(3):393-8. doi: 10.1016/j.yexmp.2015.08.013. Epub 2015 Aug 29.
10
MicroRNA role in thyroid cancer pathogenesis.微小 RNA 在甲状腺癌发病机制中的作用。
Front Biosci (Landmark Ed). 2013 Jan 1;18(2):734-9. doi: 10.2741/4135.

引用本文的文献

1
Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma.解析 DGCR8 和 miRNA 在甲状腺癌中的作用。
Cells. 2024 Mar 22;13(7):561. doi: 10.3390/cells13070561.
2
Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas.细胞组织学特征分析 miRNA 在分化型甲状腺癌中的诊断生物标志物。
Genes (Basel). 2024 Mar 21;15(3):389. doi: 10.3390/genes15030389.
3
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.

本文引用的文献

1
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.BRAF(V600E)突变与甲状腺乳头状癌患者的预后:一项15年中位随访研究
J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9. doi: 10.1210/jc.2008-0607. Epub 2008 Aug 5.
2
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.微小RNA分析作为甲状腺乳头状癌的一种潜在诊断工具
Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.
3
MicroRNAs 221 and 222 bypass quiescence and compromise cell survival.
具有滤泡结构的 RAS 突变型甲状腺肿瘤的 microRNA 表达谱分析:鉴别良恶性病变的 microRNA 特征。
J Endocrinol Invest. 2023 Aug;46(8):1651-1662. doi: 10.1007/s40618-023-02023-5. Epub 2023 Feb 7.
4
DGCR8 Microprocessor Subunit Mutation and Expression Deregulation in Thyroid Lesions.DGCR8 微处理器亚基突变与甲状腺病变中表达失调。
Int J Mol Sci. 2022 Nov 26;23(23):14812. doi: 10.3390/ijms232314812.
5
LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.长链非编码 RNA CALML3-AS1 通过海绵吸附 miR-20a-5p/RBM38 轴抑制甲状腺乳头状癌细胞的进展。
BMC Cancer. 2022 Mar 29;22(1):344. doi: 10.1186/s12885-022-09360-3.
6
miR-181a-2-3p Stimulates Gastric Cancer Progression Targeting MYLK.miR-181a-2-3p通过靶向MYLK促进胃癌进展。
Front Bioeng Biotechnol. 2021 Oct 18;9:687915. doi: 10.3389/fbioe.2021.687915. eCollection 2021.
7
The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer.微小RNA在甲状腺乳头状癌诊断和预后中的重要性
J Clin Med. 2021 Oct 15;10(20):4738. doi: 10.3390/jcm10204738.
8
MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis.基于微小RNA的风险评分预测分化型甲状腺癌患者放射性碘消融后的肿瘤进展:一项倾向评分匹配分析
Cancers (Basel). 2021 Sep 16;13(18):4649. doi: 10.3390/cancers13184649.
9
Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer.与甲状腺癌发生和预后相关的可变剪接事件。
Sci Rep. 2021 Mar 1;11(1):4841. doi: 10.1038/s41598-021-84403-6.
10
Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells.长链非编码RNA DIO3OS/let-7d/NF-κB2轴调控甲状腺癌细胞的增殖和转移。
J Cell Commun Signal. 2021 Jun;15(2):237-250. doi: 10.1007/s12079-020-00589-w. Epub 2020 Oct 15.
微小RNA 221和222绕过静止期并损害细胞存活。
Cancer Res. 2008 Apr 15;68(8):2773-80. doi: 10.1158/0008-5472.CAN-07-6754.
4
Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues.用于福尔马林固定石蜡包埋组织中微小RNA表达分析的总RNA提取方法的评估与验证
J Mol Diagn. 2008 May;10(3):203-11. doi: 10.2353/jmoldx.2008.070153. Epub 2008 Apr 10.
5
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.甲状腺肿瘤的微小RNA表达谱分析:生物学意义及诊断效用
J Clin Endocrinol Metab. 2008 May;93(5):1600-8. doi: 10.1210/jc.2007-2696. Epub 2008 Feb 12.
6
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.甲状腺癌的分子遗传学:对诊断、治疗及预后的影响
Expert Rev Mol Diagn. 2008 Jan;8(1):83-95. doi: 10.1586/14737159.8.1.83.
7
Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues.使用福尔马林固定石蜡包埋组织,比较甲状腺乳头状癌与结节性甲状腺肿中微小RNA的差异表达。
Endocr Pathol. 2007 Fall;18(3):163-73. doi: 10.1007/s12022-007-0023-7.
8
MYCN regulates oncogenic MicroRNAs in neuroblastoma.MYCN调控神经母细胞瘤中的致癌微小RNA。
Int J Cancer. 2008 Feb 1;122(3):699-704. doi: 10.1002/ijc.23153.
9
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.微小RNA(miR)-221和miR-222在人甲状腺乳头状癌中均过表达,它们调节p27Kip1蛋白水平和细胞周期。
Endocr Relat Cancer. 2007 Sep;14(3):791-8. doi: 10.1677/ERC-07-0129.
10
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.微小RNA-221和微小RNA-222的表达通过靶向p27Kip1影响人前列腺癌细胞系的增殖潜能。
J Biol Chem. 2007 Aug 10;282(32):23716-24. doi: 10.1074/jbc.M701805200. Epub 2007 Jun 14.